Cutaneous Melanoma Incidence, Mortality, and Survival in Manizales, Colombia: a Population-based Study

Overview

Journal J Int Med Res

Publisher Sage Publications

Specialty General Medicine

Date 2022 Jun 20

PMID 35722901

Authors

Juan David Rodriguez-Betancourt

Nelson Arias-Ortiz

Affiliations

Soon will be listed here.

Abstract

Objective: We estimated the cutaneous melanoma (CM) incidence, mortality, and survival in Manizales, Colombia to establish predictors for survival.

Methods: This analytical cohort study used CM incident cases during 2006 to 2015 in the Manizales Cancer Registry (n = 132). Incidence and mortality rates were standardized using the direct method. Patients were followed up until 30 November 2020. Cause-specific survival was calculated using the Kaplan-Meier method for variables of interest, with the log-rank test for differences. Cox multivariate regression models were fitted.

Results: Incidence (per 100,000) increased from 1.6 to 3.0 in men and 2.6 to 2.8 in women during 2006-2010 to 2011-2015, respectively. Mortality was low and stable. Five-year survival was 68.7%, with significant differences according to age (hazard ratio [HR] >70 vs. ≤70 years: 3.37); histological subtype (HR for melanoma not otherwise specified and HR for nodular melanoma vs lentigo malignant melanoma and superficial spreading melanoma: 17.39 and 10.16, respectively); and clinical stage (HR stages III-IV vs. stages I-II: 5.94).

Conclusion: CM is characterized by increasing incidence and unfavorable prognosis, particularly in patients aged >70 years, with melanoma not otherwise specified and nodular melanoma, and advanced stages. Promoting photoprotection and early detection and management of suspicious skin lesions is crucial.

Citing Articles

Melanoma in a Colombian population: a survival study.

Florez M, Moreno Gomez G, Florez M, Bueno I, Gomez J, Gomez M Melanoma Manag. 2025; 11(1):2382079.

PMID: 39869442 PMC: 11318695. DOI: 10.1080/20450885.2024.2382079.

Skin health of community-living older people: a scoping review.

Kottner J, Fastner A, Lintzeri D, Blume-Peytavi U, Griffiths C Arch Dermatol Res. 2024; 316(6):319.

PMID: 38822889 PMC: 11144137. DOI: 10.1007/s00403-024-03059-0.

Continuing benefits of the Montreal Protocol and protection of the stratospheric ozone layer for human health and the environment.

Madronich S, Bernhard G, Neale P, Heikkila A, Andersen M, Andrady A Photochem Photobiol Sci. 2024; 23(6):1087-1115.

PMID: 38763938 DOI: 10.1007/s43630-024-00577-8.

Descriptive Epidemiology of Melanoma Diagnosed between 2010 and 2014 in a Colombian Cancer Registry and a Call for Improving Available Data on Melanoma in Latin America.

de Vries E, Uribe C, Beltran Rodriguez C, Caparros A, Meza E, Gil F Cancers (Basel). 2023; 15(24).

PMID: 38136393 PMC: 10741499. DOI: 10.3390/cancers15245848.

Differences and Similarities in Epidemiology and Risk Factors for Cutaneous and Uveal Melanoma.

Branisteanu D, Porumb-Andrese E, Starica A, Munteanu A, Toader M, Zemba M Medicina (Kaunas). 2023; 59(5).

PMID: 37241175 PMC: 10224090. DOI: 10.3390/medicina59050943.

References

Lattanzi M, Lee Y, Simpson D, Moran U, Darvishian F, Kim R . Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy. J Natl Cancer Inst. 2018; 111(2):180-188. PMC: 7962783. DOI: 10.1093/jnci/djy086. View

Chopra A, Sharma R, Rao U . Pathology of Melanoma. Surg Clin North Am. 2019; 100(1):43-59. DOI: 10.1016/j.suc.2019.09.004. View

Prado G, DAmore P, Tagliero A, Florez-White M, Acuna J . A cross-sectional study of trends in the stage of melanoma at diagnosis in the United States from 2001-2011. J Am Acad Dermatol. 2016; 75(5):1057-1059. DOI: 10.1016/j.jaad.2016.07.030. View

Lino-Silva L, Dominguez-Rodriguez J, Aguilar-Romero J, Martinez-Said H, Salcedo-Hernandez R, Garcia-Perez L . Melanoma in Mexico: Clinicopathologic Features in a Population with Predominance of Acral Lentiginous Subtype. Ann Surg Oncol. 2016; 23(13):4189-4194. DOI: 10.1245/s10434-016-5394-x. View

Nunes L, Quintella Mendes G, Koifman R . Acral melanoma: a retrospective cohort from the Brazilian National Cancer Institute (INCA). Melanoma Res. 2018; 28(5):458-464. DOI: 10.1097/CMR.0000000000000476. View

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007; 147(8):573-7. DOI: 10.7326/0003-4819-147-8-200710160-00010. View

Smith A, Lambert P, Rutherford M . Understanding the impact of sex and stage differences on melanoma cancer patient survival: a SEER-based study. Br J Cancer. 2020; 124(3):671-677. PMC: 7851379. DOI: 10.1038/s41416-020-01144-5. View

de Vries E, Uribe C, Pardo C, Lemmens V, Van de Poel E, Forman D . Gastric cancer survival and affiliation to health insurance in a middle-income setting. Cancer Epidemiol. 2015; 39(1):91-6. DOI: 10.1016/j.canep.2014.10.012. View

Sarfati D, Blakely T, Pearce N . Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol. 2010; 39(2):598-610. DOI: 10.1093/ije/dyp392. View

10.

de Vries E, Sierra M, Pineros M, Loria D, Forman D . The burden of cutaneous melanoma and status of preventive measures in Central and South America. Cancer Epidemiol. 2016; 44 Suppl 1:S100-S109. DOI: 10.1016/j.canep.2016.02.005. View

11.

Amini A, Rusthoven C, Waxweiler T, Jones B, Fisher C, Karam S . Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States. J Am Acad Dermatol. 2015; 74(2):309-16. DOI: 10.1016/j.jaad.2015.09.054. View

12.

Koblinski J, Maykowski P, Zeitouni N . Disparities in melanoma stage at diagnosis in Arizona: A 10-year Arizona Cancer Registry study. J Am Acad Dermatol. 2021; 84(6):1776-1779. DOI: 10.1016/j.jaad.2021.02.045. View

13.

Teramoto Y, Keim U, Gesierich A, Schuler G, Fiedler E, Tuting T . Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients. Br J Dermatol. 2017; 178(2):443-451. DOI: 10.1111/bjd.15803. View

14.

Schmerling R, Loria D, Cinat G, Ramos W, Cardona A, Sanchez J . Cutaneous melanoma in Latin America: the need for more data. Rev Panam Salud Publica. 2012; 30(5):431-8. DOI: 10.1590/s1020-49892011001100005. View

15.

Borkowska A, Szumera-Cieckiewicz A, Spalek M, Teterycz P, Czarnecka A, Rutkowski P . Clinicopathological Features and Prognostic Factors of Primary Acral Melanomas in Caucasians. J Clin Med. 2020; 9(9). PMC: 7563150. DOI: 10.3390/jcm9092996. View

16.

de Lima Vazquez V, Silva T, Vieira M, de Oliveira A, Lisboa M, de Andrade D . Melanoma characteristics in Brazil: demographics, treatment, and survival analysis. BMC Res Notes. 2015; 8:4. PMC: 4302717. DOI: 10.1186/s13104-015-0972-8. View

17.

Bay C, Kejs A, Storm H, Engholm G . Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989-2011. Cancer Epidemiol. 2014; 39(1):1-7. DOI: 10.1016/j.canep.2014.10.010. View

18.

Greenwald H, Friedman E, Osman I . Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model. Melanoma Res. 2011; 22(1):1-8. PMC: 3253944. DOI: 10.1097/CMR.0b013e32834e6aa0. View

19.

Fitzmaurice C, Akinyemiju T, Al Lami F, Alam T, Alizadeh-Navaei R, Allen C . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2018; 4(11):1553-1568. PMC: 6248091. DOI: 10.1001/jamaoncol.2018.2706. View

20.

Caini S, Gandini S, Sera F, Raimondi S, Fargnoli M, Boniol M . Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer. 2009; 45(17):3054-63. DOI: 10.1016/j.ejca.2009.05.009. View